Clinical Trials Browser

Phase 1 × soluble LAG-3 protein, human × 30 days × Clear all

NCT03252938 2026-02-19

INSIGHT

Phase 1 Active not recruiting

GenitourinaryGynecologic

Carcinoma, Transitional Cell, Peritoneal Neoplasms